Vortioxetine Treatment for Anxiety Disorder: A Meta-Analysis Study.

@article{Yee2018VortioxetineTF,
  title={Vortioxetine Treatment for Anxiety Disorder: A Meta-Analysis Study.},
  author={Anne Yee and Chong Guan Ng and Loh Huai Seng},
  journal={Current drug targets},
  year={2018},
  volume={19 12},
  pages={
          1412-1423
        }
}
BACKGROUND Vortioxetine is a multimodal antidepressant that has been developed for the treatment of major depressive and anxiety disorders. The aim of this review is to quantitatively synthesize all data of the efficacy, safety and tolerability of Vortioxetine in treating anxiety disorder. METHOD Terms of "Vortioxetine" OR "LuAA21004" AND "anxiety" OR "fear" OR "panic" OR "phobia" were searched. A total of two phase II and five phase III clinical trials were found. RESULTS Vortioxetine was… 

Vortioxetine treatment for generalised anxiety disorder: a meta-analysis of anxiety, quality of life and safety outcomes

The results suggest that vortioxetine did not improve the GAD symptoms, QoL and functional status impairment of patients with GAD, but it was safe and well tolerated.

Vortioxetine vs. Other Antidepressants in Patients with Major Depressive Episode With or Without Substance Use Disorder

MDEs responded to vortioxetine similarly to OADs by improving in depression, general psychopathology, anxiety, suicidal thinking, and quality-of-life, independently from SUD comorbidity.

Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial

This is the first study to provide evidence for the therapeutic effect of vortioxetine on negative symptoms as an adjunctive to treatment with antipsychotics in patients with schizophrenia.

Treatment of anxiety disorders in clinical practice: a critical overview of recent systematic evidence

Computer-delivered psychological interventions were helpful for treating anxiety of low-to-moderate intensity, but the therapist-oriented approaches had greater results, and recommendations for regular exercise, mindfulness, yoga, and safety behaviors were applicable to anxiety.

Drawing Therapy onMedication Compliance and Sleep Quality in Patients with Anxiety Disorders

DT-assisted tandospirone citrate can effectively improve the clinical symptoms of patients with anxiety disorders, improve medication compliance, sleep quality, and quality of life, and have a certain degree of safety.

Clinical Analysis on the Effects of Tandospirone Citrate Assisted by Drawing Therapy on Medication Compliance and Sleep Quality in Patients with Anxiety Disorders

DT-assisted tandospirone citrate can effectively improve the clinical symptoms of patients with anxiety disorders, improve medication compliance, sleep quality, and quality of life, and have a certain degree of safety.

Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double‐blind randomized trial

The efficacy and tolerability of vortioxetine versus sertraline on symptoms of depression in elderly patients with MDD is explored.

Panic Disorder Induced by the Coronavirus Disease Pandemic in a Patient with Organic Mood Disorder Successfully Treated with Vortioxetine

The present case suggests that vortioxetine augmentation can improve symptoms of depressive state and panic disorder induced by the COVID-19 pandemic.